financetom
Business
financetom
/
Business
/
Permira-backed womenswear retailer Reformation valued at $886 million in NYSE debut
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Permira-backed womenswear retailer Reformation valued at $886 million in NYSE debut
Jul 30, 2026 10:41 AM

July 30 (Reuters) - Permira-backed womenswear retailer

Reformation was valued at $886.1 million after its

shares opened flat in their NYSE debut on Thursday.

The Vernon, California-based company's shares opened at $15

apiece, the same as its offer price. The retailer and some of

its shareholders had raised $211 million in its IPO on

Wednesday.

The debut comes as the number of U.S. consumer and retail

IPOs are at their lowest in a decade, even as the broader IPO

market rebounds.

Founded in 2009 as a vintage clothing boutique in Los

Angeles, Reformation markets itself as the largest sustainable

​brand that designs and sells women's apparel and accessories.

"During the peak of ESG investing, a sustainability

narrative often attracted significant investor interest," said

Kat Liu, vice president at IPO research firm IPOX.

"Today, investors are placing much greater emphasis on

financial performance. Sustainability can certainly strengthen a

brand and help build customer loyalty, but it can no longer

compensate for weak fundamentals."

Private ​equity firm Permira, which has long track record of

investing in consumer companies, ​acquired a majority ⁠stake in

Reformation in 2019. Permira's portfolio also includes brands

such as K-Way and Italian manufacturing hub Gruppo Florence.

Reformation has five core product groups: dresses, bottoms,

tops, sweaters and accessories. Its strategy is based on testing

new styles in small quantities, launching tests twice a week on

its website and once a week in its stores, and then iterating on

proven designs, it said in its IPO filing.

It has more than a million active customers across its

direct-to-consumer channels, it added.

"A high percentage of returning customers suggests genuine

brand loyalty rather than one-time demand. Those customers are

generally less expensive to retain, tend to spend more over

time, and can make revenue more predictable," Liu said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
USITC says Russian palladium does not harm America cos, ends probe
USITC says Russian palladium does not harm America cos, ends probe
May 29, 2026
WASHINGTON, May 29 (Reuters) - Russian unwrought palladium, a metal used to reduce emissions in gasoline vehicles, does not injure American companies, the U.S. International Trade Commission said on Friday, ending Washington's anti-dumping investigation. The United States had been probing whether dumped or subsidized palladium from Russia harmed the U.S. industry, with the U.S. Department of Commerce last weekseparately deciding...
Market Chatter: Nikon Eyes Lithography Comeback With Price Play Against ASML
Market Chatter: Nikon Eyes Lithography Comeback With Price Play Against ASML
May 29, 2026
03:01 PM EDT, 05/29/2026 (MT Newswires) -- Nikon is pushing to reclaim ground in the semiconductor photolithography equipment market by undercutting Dutch rival ASML ( ASML ) on price, Nikkei Asia reported Friday, citing the Japanese company's president and chief executive, Yasuhiro Ohmura. Nikon produces many components in-house, giving it a structural cost advantage, Ohmura told Nikkei. The company is...
Johnson & Johnson Says Lung Cancer Study on Rybrevant Plus Lazcluze Suggests Potential for More Durable Disease Control
Johnson & Johnson Says Lung Cancer Study on Rybrevant Plus Lazcluze Suggests Potential for More Durable Disease Control
May 29, 2026
03:05 PM EDT, 05/29/2026 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday that updated Phase 1/1b CHRYSALIS-2 data showed Rybrevant plus Lazcluze achieved a median overall survival of 41 months in patients with advanced non-small cell lung cancer with atypical epidermal growth factor receptor mutations. The company said the results add to the evidence showing potential of...
AGNC Investment Launches $2 Billion At-The-Market Offering
AGNC Investment Launches $2 Billion At-The-Market Offering
May 29, 2026
03:01 PM EDT, 05/29/2026 (MT Newswires) -- AGNC Investment ( AGNC ) announced Friday an at-the-market offering program to sell up to $2 billion of its common stock from time to time. Shares fell around 1.2% in recent trading. Price: 10.43, Change: -0.12, Percent Change: -1.14 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved